“The Environmental Protection Agency’s (EPA) independent board of science advisers had harsh words for an agency plan to limit the types of studies it considers when crafting regulations, saying the EPA had failed to justify the need for the policy.
The policy was first proposed by former EPA Administrator Scott Pruitt in 2018 to battle “secret science.” He argued that in order to increase transparency, the agency should limit consideration of studies that don’t share their underlying data….
The SAB’s review is consistent with longstanding criticism of the proposal, as science and medical groups have argued it will lead the EPA to ignore important public health research that must protect the privacy of human subjects….”
“But now, in an attempt to extend solidarity during the coronavirus crisis, JSTOR has announced free access to over 6,000 books and 150 journals. Great news, right? Except it’s not. Twitter users have pointed out that JSTOR has not released any essay that was under paywall; instead, it is just replugging those articles and papers that users already had open access to.
Essentially, JSTOR has simply tried to score brownie points on the back of a deadly virus that has claimed more than 10,000 lives globally. But then, the archival site is not known to be particularly kind to people.
Just for perspective, JSTOR has been unable to bring itself to give academics and researchers open access to ‘publicly sourced’ content at a time when the whole world is under quarantine and going through an unprecedented and unnatural crisis. Then again, it’s also a time to get on the bandwagon and be appreciated for doing nothing….”
“The Interior Department is pushing ahead with a controversial proposal that would prohibit the agency from considering scientific studies that don’t make all of their underlying data public.
Critics argue that the move, described by the agency as an effort to increase transparency, would sideline landmark scientific research, particularly in cases where revealing such data would result in privacy violations.
The proposal, dubbed the Promoting Open Science rule, mirrors a similar effort at the Environmental Protection Agency (EPA), which critics argue would block that agency from considering renowned public health studies….”
Abstract: The terms ‘open’ and ‘openness’ are widely used across the current higher education environment particularly in the areas of repository services and scholarly communications. Open-access licensing and open-source licensing are two prevalent manifestations of open culture within higher education research environments. As theoretical ideals, open-licensing models aim at openness and academic freedom. But operating as they do within the context of global neoliberalism, to what extent are these models constructed by, sustained by, and co-opted by neoliberalism? In this paper, we interrogate the use of open-licensing within scholarly communications and within the larger societal context of neoliberalism. Through synthesis of various sources, we will examine how open access licensing models have been constrained by neoliberal or otherwise corporate agendas, how open access and open scholarship have been reframed within discourses of compliance, how open-source software models and software are co-opted by politico-economic forces, and how the language of ‘openness’ is widely misused in higher education and repository services circles to drive agendas that run counter to actually increasing openness. We will finish by suggesting ways to resist this trend and use open-licensing models to resist neoliberal agendas in open scholarship.
“A proposed rule by the Environmental Protection Agency (EPA) that allegedly aims to strengthen transparency in regulatory science suggests that science is broken. It isn’t.
We know it works because we can see the life-saving transplant technologies, hurricane forecasts, new medications, pest-resistant crops, and countless other breakthroughs that exist because of science. This discipline isn’t perfect, but it is the best tool available to safeguard the planet and its people.
Last year, the EPA proposed a rule requiring that scientists disclose all raw data before any study conclusions would be considered. The rule, titled “Strengthening Transparency in Regulatory Science,” would apply retroactively to regulations already in place. It would make it harder to enact new regulations, because many studies from the past rely on personal medical information that was collected under confidentiality agreements and include consensus from reports that may not have shared all of the data according in ways compliant with the proposed rule….”
“Eighteen months after articulating our concerns (1) regarding the 2018 “Strengthening Transparency in Regulatory Science” rule proposed by the Environmental Protection Agency (EPA) (2), we have become more concerned in response to recent media coverage and a 13 November hearing on the role of science in decision-making at the EPA. These events suggest that the proposed rule is now moving toward implementation; whether it includes amendments sufficient to address the concerns raised by us and many others remains a question.
Our previous statement on the proposed rule, authored and published by the editors-in-chief of five major scientific journals in May 2018, reflected alarm that the proposal’s push for “transparency” would be used as a mechanism for suppressing the use of relevant scientific evidence in policy-making, including public health regulations. After the public comment period for the proposed rule closed, the EPA reported more than 590,000 comments from individuals and scientific, medical, and legal groups, many of which articulated similar concerns (3).
As leaders of peer-reviewed journals, we support open sharing of research data, but we also recognize the validity of scientific studies that, for confidentiality reasons, cannot indiscriminately share absolutely all data. Datasets featuring personal identifiers—including studies evaluating genomes of thousands of people to characterize medically relevant genetic variants—are but one example. Such data may be critical to developing new drugs or diagnostic tools but cannot be shared openly; even anonymized personal data can be subject to re-identification, and it has been a longstanding practice for agencies and journals to acknowledge the value of data privacy adjustments. The principles of careful data management, as they inform medicine, are just as applicable to data regarding environmental influences on public health. Discounting evidence from the decision-making process on the basis that some data are confidential runs counter to the EPA stated mission “to reduce environmental risks…based on the best available scientific information” (4)….
We urge the EPA to continue to adopt an approach that ensures the data used in decision-making are the best available, which will at times require consideration of peer-reviewed scientific data, not all of which may be open to all members of the public. The most relevant science, vetted through peer review, should inform public policy. Anything less will harm decision-making that claims to protect our health….”
“The most glaring disregard for science is at the Environmental Protection Agency. One blatant example has been an attempt to weaken the Mercury and Air Toxics Standards that were built on deep research into the health threats from mercury, arsenic, lead and other pollutants, which come in part from coal-burning power plants. We urge you to uphold those standards, and to fight the stream of reckless rollbacks by both the EPA and the Department of the Interior of measures that safeguard people and the environment. Clean water, clean air and clean land should not be sacrificed for commercial gain.
Another egregious step you should fight is the EPA’s proposed “Strengthening Transparency in Regulatory Science” rule. Despite the nice-sounding name, it would force EPA to use only studies that make all data publicly available—including sensitive, personal information about individuals who were involved in health studies. In effect, it would prevent EPA from using important research. A concise argument against the measure was published by the editors-in-chief of Nature, Science, PLOS, PNAS and other major journals….”
“The Environmental Protection Agency (EPA) plans to pursue next year a final version of its much-criticized rule that would restrict the scientific studies it can use to justify regulations.
In a Friday interview with The Hill, acting EPA chief Andrew Wheeler dismissed the idea that the science transparency regulation was on the “back burner” since the administration recently listed it as a “long-term” regulatory action.
“It is not a back-burner issue. I feel strongly about that,” Wheeler said. “And we will move forward to finalize that next year.” …
Wheeler rejected the main criticism from opponents of the rule, that it is meant to restrict the agency’s ability to regulate by putting out of reach large bodies of valuable science, such as many epidemiological studies that by their nature cannot be reproduced.
“I don’t think it’s designed to restrict what we use. It’s designed to get the information out to the public. The critics look at it as ‘oh, you’re trying to get rid of a lot of the studies, you’re trying to restrict what the agency can use.’ No,” he said. …
California Attorney General Xavier Becerra, who has sued the Trump administration’s EPA numerous times — frequently with success — said if the science rule moves forward, he’ll fight it….”
“A furious public response has slowed down the Trump administration’s plan to stop using so-called “secret science,” a move that scientists complained could have restricted the types of research used to regulate toxins, pesticides and pollution….”
“The Environmental Protection Agency (EPA) appears to have put a deeply controversial plan limiting the use of scientific data in policymaking on hold for the time being. The move follows significant outcry from experts and the agency’s own staff….
On its face, that push for transparency might resonate with some — but experts have repeatedly emphasized that confidential data is private for a reason. Making it public could violate patient privacy or industry confidentiality, in many instances breaking the law and potentially allowing for distortions of the information. Limiting the data government officials can use, meanwhile, could hinder efforts to protect both human health and the environment….”